HealthcareInvestment

Apollo Hospitals: A Healthy Outlook and Robust Performance Ahead

A New Wave of Money Flows Into Africa’s Health Systems

Bain Capital's Monumental Asia Fund: $10.5 Billion War Chest Ready for Investment

Georgia's MiMedx Group Acquired in Staggering $1.3 Billion Deal

Inspira Technologies' Transformative 2025: Unpacking a Year of Strategic Growth and Innovation

Navigating the Future of Health: A Deep Dive into Nomura Healthcare Fund's Q4 2025 Insights

Punjab's Vision 2026: A Landmark Budget Focused on Women's Empowerment and Holistic Growth

Medtronic's MiniMed: A Lingering Doubt in the Diabetes Space

MiniMed's Grand Debut: Medtronic's Diabetes Arm Goes Public

Nova Leap Health Hits New Heights: A Banner Year for Revenue and Earnings!

GSK's Bold Move: A $1.8 Billion Bet on the Future of Pulmonary Hypertension Treatment

India's Healthcare Boom: A Tale of Two Markets

Why Barclays Still Sees Eli Lilly as the Undisputed Champion in the Exploding GLP-1 Arena, Even as Rivals Crowd In

Navigating the World of Concierge Medicine: Your Personalized Path to Health and Wellness

UnitedHealth: Navigating Turbulent Waters Post-Downturn

UnitedHealth Group: A Contrarian's View on Recovery Amidst Turmoil

UnitedHealth Group: The Truth Behind ACA and MA Fears – Why Investors Might Be Overreacting

Anchor Health Properties Makes a Bold Move: Acquiring Chestnut Funds to Fuel Massive Growth

UnitedHealth Group: A Quiet Giant in Healthcare – Is Now the Time to Pay Attention?

Bristol Myers Squibb: Navigating the Patent Storm, Still a Cash Machine?

India's Private Equity Landscape Navigates Global Turbulence: A Look at the 2023 Slowdown

Astrana Health Gets a Boost: Needham Initiates with 'Buy' Rating

HCA Healthcare: A Closer Look at a Healthcare Giant Balancing Patient Care and Investor Returns

Jim Cramer's Gut-Wrenching Verdict: 'This Healthcare Stock is Horrendous'

Park Mediworld IPO: India's 100th Mainboard Listing of 2025 Opens Soon!

NephroPlus IPO: A Deep Dive into India's Dialysis Giant's Public Offering

NephroPlus Gears Up for Major IPO: Asia's Dialysis Giant Eyes Public Debut

The Quiet Confidence: Why a Banking Giant Doubled Down on Medical Innovation

The Great Healthcare Pivot: Why Smart Money's Eyeing What's Next

A Glimmer of Hope, Yet the Shadows of Shortfall Linger: The WHO's TB Report

The Tale of Two Titans: Bausch Health and Dr. Reddy's Navigate a Volatile Market

A New Chapter for Health: Epsom's Surgical Hub Aims to Rewrite Waiting Lists

The Shifting Sands of Biotech: What Analysts Really Think of Bicycle Therapeutics

The Healing Frontier: Yzi Labs Dives Headfirst into Regenerative Medicine's Bold Promise

The Pulse of Health: Why One Diagnostic Giant Might Just Be Poised for a New Chapter

Nigeria's Ambitious Dream: Can It Cure Its Own, And Then The World?

The Quiet Confidence: Why Searle & Co. Just Doubled Down on Johnson & Johnson

The Prize Fight for Progress: Pfizer Snags Metacrine in a High-Stakes Metabolic Drug Scramble

The Battle for the Next Blockbuster: Pfizer Steps Up in the Obesity Drug Wars